(Reuters) – Eli Lilly anticipates to start providing its weight-loss drugs in Hong Kong as early as completion of this yr, Bloomberg News reported on Sunday.
The enterprise has really gotten the Hong Kong federal authorities authorization to market its tirzepatide photographs– branded as Mounjaro– in a gadget referred to as Kwikpen for each long-lasting weight administration and type 2 diabetes mellitus, Eli Lilly knowledgeable Bloomberg in a declaration.
(Reporting by Jahnavi Nidumolu in Bengaluru)
